Italia markets open in 4 hours 19 minutes

T2 Biosystems, Inc. (0A57.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,1046-0,0024 (-2,24%)
Alla chiusura: 06:27PM BST
Schermo intero
Caricamento grafico interattivo in corso...
  • GlobeNewswire

    T2 Biosystems Announces BARDA Exercise of Contract Option 3 Valued at $3.7 Million

    Advances U.S. Clinical Trials and FDA Submission for T2Resistance and T2Biothreat PanelsLEXINGTON, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, is providing

  • GlobeNewswire

    T2 Biosystems Announces Commercial Expansion Through Distributor in Baltic Region

    LEXINGTON, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a territory exclusive distribution agreement in the Baltic Region, including Lithuania, Latvia, and Estonia. Under the terms of the agreement, T2 Biosystems will sell T2Dx® Instruments, along with T2Bacteria®, T2Candida® and T2Resistance® Panels through the distributor. The execution of

  • GlobeNewswire

    T2 Biosystems to Participate in the H.C. Wainwright Global Investment Conference

    LEXINGTON, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to participate in the upcoming H.C. Wainwright Global Investment Conference in New York, New York. Management is scheduled to present on Tuesday, September 13, 2022, at 3:00pm ET. Interested parties may access a live and recorded webcast of the presentation on the “Investors” section of the Compa